Re-I Chin, MD, MSCI

503-216-2195
Areas of Focus: 
Head & Neck Cancers
Lung Cancers
Breast Cancers
Gastrointestinal Cancer
Gynecologic Cancer, including High Dose Rate Brachytherapy, Stereotactic Body Radiation Therapy (SBRT), CT & MR-based Adaptive Radiotherapy (ART)

About Me

My mission as an oncologist is to not only provide evidence-based treatments to heal my patients but also to instill hope in them and their loved ones. I am committed to forging personal and compassionate connections with each patient, treating them as cherished members of my own family.

- Re-I Chin, MD, MSCI

Dr. Chin chose a career as a radiation oncologist to utilize state-of-the-art technology to deliver precise treatments, while collaborating closely with the multidisciplinary oncology team to improve the lives of patients with cancer. 

Dr. Chin was trained in Computed Tomography and Magnetic Resonance-Guided Adaptive Radiotherapy (ART) during residency. She also trained in gynecologic high-dose rate brachytherapy used to treat cervical/endometrial cancers. 

Concurrently with her residency training, Dr. Chin completed a Master of Science in Clinical Investigation (MSCI), which will help her bring advances in clinical research to the clinic. 

 

Other Interests: 

Dr. Chin likes living in Portland because of the endless greens all around, diverse food options, and beautiful outdoor activities. 

Outside of work, Dr. Chin enjoys traveling, trying new restaurants, photography, playing badminton, and spending time with her family, dog, and cats.

 

My Work

Hospitals Served: 
Providence St. Vincent Medical Center
Specialties: 
Areas of Focus: 
Head & Neck Cancers
Lung Cancers
Breast Cancers
Gastrointestinal Cancer
Gynecologic Cancer, including High Dose Rate Brachytherapy, Stereotactic Body Radiation Therapy (SBRT), CT & MR-based Adaptive Radiotherapy (ART)
Stereotactic Radiosurgery (Gamma Knife)

Education & Honors

Board Certification: 
Radiation Oncology – Board Eligible
Education & Training: 
  • Master of Science in Clinical Investigation (MSCI), Washington University, St. Louis, MO, 2021
  • Resident Intern, Transitional Year, Mercy Hospital, St. Louis, MO, 2019
  • Doctor of Medicine, Saint Louis University School of Medicine, ST. Louis, MO, 2018
  • Bachelor of Arts, Biochemistry, Washington University, St. Louis, MO, 2013
Honors: 
  • American Radium Society (ARS) Early Career Oncologist Award, 2021
  • American College of Radiation Oncology (ACRO) Travel Grant, 2021
  • American College of Radiation Oncology (ACRO) Resident Seed Grant, 2020-2021
  • Best of ASTRO Abstract, 2020
  • Radiological Society of North America (RSNA) Annual Conference Travel Award, 2016
  • Radiological Society of North America (RSNA) Research Medical Student Grant, 2015
  • Philip & Lillian Katzman Scholarship, 2014-2018
  • Florence Moog Scholar; Four-year Full-tuition Merit Scholarship, 2009-2013
Publications: 
  • Chin RI, Schiff JP, Bommireddy A, Kang KH, Price AT, Green OL, Andruska N, Huang Y, Korenblat K, Parikh PJ, Olsen J, Samson PP, Henke LE, Kim H, Badiyan SN. Clinical Outcomes of Patients with Unresectable Primary Liver Cancer Treated with MR-guided Stereotactic Body Radiation Therapy: A Six-year Experience. Clin Transl Radiat Oncol. 2023.
  • Chin RI, Schiff JP, Shetty AS, Pedersen KS, Aranha O, Huang Y, Hunt SR, Glasgow SC, Byrnes K, Tan BR, Wise PE, Silveira ML, Smith RK, Suresh R, Byrnes K, Badiyan SN, Henke LE, Mutch MG, Kim H. Circumferential Resection Margin as Predictor of Non-clinical Complete Response in Nonoperative Management of Rectal Cancer. Diseases of the Colon & Rectum. 2023. (PMID: 36876988)
  • Schiff JP, Price A, Stowe HB, Laugeman E, Chin RI, Hatscher C, Pryser E, Cai B, Hugo GD, Kim H, Badiyan SN, Robinson CG, and Henke LE. Simulated computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR) for the treatment of locally advanced pancreatic cancer. Radiotherapy and Oncology. 2022. (PMID: 36063981)
  • Chin RI, Bommireddy A, Fraum TJ, Ludwig DR, Huang Y, Zoberi JE, Garcia-Ramirez JL, Maughan NM, Chapman W, Korenblat K, Henke LE, Kim H, and Badiyan SN. Clinical outcomes of patients with unresectable primary liver cancer treated with yttrium-90 radioembolization with an escalated dose. Advances in Radiation Oncology. 2022. (PMID: 35814852)
  • Chin RI* (co-first author), Otegbeye EE* (co-first author), Kang KH, Chang SH, McHenry S, Roy A, Chapman WC Jr, Henke LE, Badiyan SN, Pedersen KS, Tan BR, Glasgow SC, Mutch MG, Samson P, Kim H. Cost-effectiveness of total neoadjuvant therapy with short-course radiation therapy for resectable locally advanced rectal cancer. JAMA Network Open. 2022. (PMID: 35103791)
  • Chin RI, Schiff JP, Brenneman RJ, Gay HA, Thorstad WL, Lin AJ. A Rational Approach to Unilateral Neck Radiation for Head and Neck Cancers in the Era of Immunotherapy. Cancers. 2021. (PMID: 34771432)
  • Chin RI, Roy A, Pedersen KS, Huang Y, Hunt SR, Glasgow SC, Tan BR, Wise P, Silviera ML, Smith RK, Suresh R, Badiyan S, Shetty AS, Henke LE, Mutch MG, Kim H. Clinical Complete Response in Patients with Rectal Adenocarcinoma Treated with Short-Course Radiation Therapy and Nonoperative Management. International Journal of Radiation Oncology, Biology, Physics. 2021. (PMID: 34653579)
  • Chin RI* (co-first author), Rao YJ* (co-first author), Hwang MY, Spencer CR, Pierro M, DeWees T, Patel P, Gay HA, Daly M, Haughey BH, Nussenbaum B, Adkins DR, Wildes T, Lewis JS, Thorstad WL. Comparison of Unilateral Versus Bilateral Intensity Modulated Radiation for Surgically-treated Squamous Cell Carcinoma of the Palatine Tonsil. Cancer. 2017. (PMID 28881377)
  • Rao YJ* (co-first author), Chin RI* (co-first author), Hui C, Mutch DG, Powell MA, Schwarz JK, Grigsby PW, Markovina S. Improved Survival with Definitive Chemoradiation Compared to Definitive Radiation Alone in Squamous Cell Carcinoma of the Vulva: a Review of the National Cancer Database. Gynecology Oncology. 2017. (PMID: 28662775)
  • Chin RI, Spencer CR, Dewees T, Hwang MY, Patel P, Sinha P, Gay H, Haughey BH, Nussenbaum B, Adkins D, Lewis JS, Thorstad WL. Re-evaluation of Postoperative Radiation Dose in the Management of HPV+ Oropharyngeal cancer. Head & Neck. 2016. (PMID 27152851)
Other Activities: 
  • Member, Alpha Omega Alpha (AOA)
  • Member, American Board of Radiology (ABR)
  • Member, Radiological Society of North America (RSNA)
  • Member, American Society for Radiation Oncology (ASTRO)
  • Member, American Association for Cancer Research (AACR)
  • Member, American College of Radiation Oncology (ACRO)